Cite
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors
MLA
Antonino Catalano, et al. Bone Health Assessment by Quantitative Ultrasound and Dual-Energy x-Ray Absorptiometry in Postmenopausal Women with Breast Cancer Receiving Aromatase Inhibitors. Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....99ec7970ba231ec148e2822bc7fbfc87&authtype=sso&custid=ns315887.
APA
Antonino Catalano, Elisabetta Morini, Giuseppe Natale, Marco Atteritano, Agostino Gaudio, Giorgio Basile, Anastasia Xourafa, Antonino Lasco, Rita Maria Agostino, Nunziata Morabito, & Vincenzo Adamo. (2017). Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors.
Chicago
Antonino Catalano, Elisabetta Morini, Giuseppe Natale, Marco Atteritano, Agostino Gaudio, Giorgio Basile, Anastasia Xourafa, et al. 2017. “Bone Health Assessment by Quantitative Ultrasound and Dual-Energy x-Ray Absorptiometry in Postmenopausal Women with Breast Cancer Receiving Aromatase Inhibitors,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....99ec7970ba231ec148e2822bc7fbfc87&authtype=sso&custid=ns315887.